These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 17509328

  • 1. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
    Sahai A, Khan MS, Dasgupta P.
    J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
    [Abstract] [Full Text] [Related]

  • 2. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A, Dowson C, Khan MS, Dasgupta P.
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF, Botox Detrusor Hyperreflexia Study Team.
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [Abstract] [Full Text] [Related]

  • 5. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.
    Khan S, Kessler TM, Apostolidis A, Kalsi V, Panicker J, Roosen A, Gonzales G, Haslam C, Elneil S, Fowler CJ, Dasgupta P.
    J Urol; 2009 Apr; 181(4):1773-8. PubMed ID: 19233414
    [Abstract] [Full Text] [Related]

  • 6. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [Abstract] [Full Text] [Related]

  • 7. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.
    Sahai A, Dowson C, Khan MS, Dasgupta P, GKT Botulinum Study Group.
    Urology; 2010 Mar; 75(3):552-8. PubMed ID: 20035984
    [Abstract] [Full Text] [Related]

  • 8. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity.
    Rajkumar GN, Small DR, Mustafa AW, Conn G.
    BJU Int; 2005 Oct; 96(6):848-52. PubMed ID: 16153215
    [Abstract] [Full Text] [Related]

  • 9. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A, Sangster P, Kalsi V, Khan MS, Fowler CJ, Dasgupta P.
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [Abstract] [Full Text] [Related]

  • 10. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC.
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Jeffery S, Fynes M, Lee F, Wang K, Williams L, Morley R.
    BJU Int; 2007 Dec; 100(6):1302-6. PubMed ID: 17979928
    [Abstract] [Full Text] [Related]

  • 12. Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder.
    Sahai A, Khan MS, Le Gall N, Dasgupta P, GKT Botulinum Study Group.
    Urology; 2008 Mar; 71(3):455-9. PubMed ID: 18342186
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC.
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C.
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [Abstract] [Full Text] [Related]

  • 15. The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study.
    Mehnert U, Birzele J, Reuter K, Schurch B.
    J Urol; 2010 Sep; 184(3):1011-6. PubMed ID: 20643431
    [Abstract] [Full Text] [Related]

  • 16. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M.
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G, Elzayat E, Delapparent T, St-Denis B, Lemieux MC, Corcos J.
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [Abstract] [Full Text] [Related]

  • 18. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?
    Kessler TM, Danuser H, Schumacher M, Studer UE, Burkhard FC.
    Neurourol Urodyn; 2005 Mar; 24(3):231-6. PubMed ID: 15747344
    [Abstract] [Full Text] [Related]

  • 19. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A, Mearini E, Del Zingaro M, Porena M.
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [Abstract] [Full Text] [Related]

  • 20. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
    Del Popolo G, Filocamo MT, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G, Nicita G.
    Eur Urol; 2008 May; 53(5):1013-19. PubMed ID: 17950989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.